The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.

Latest News

FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry

November 29th 2023

BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.

Study: Black Patients Less Likely than Others to Receive MRI Assessment of Cognitive Impairment
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment

November 27th 2023

Emerging AI Software for Brain MRI Gets FDA Nod
Emerging AI Software for Brain MRI Gets FDA Nod

November 21st 2023

Could an Emerging AI System Lead to Earlier Autism Detection on DT-MRI?
Could an Emerging AI System Lead to Earlier Autism Detection with DT-MRI?

November 21st 2023

Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI

November 15th 2023

Latest CME Events & Activities

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 10, 2024

View More

9th Annual School of Gastrointestinal Oncology® (SOGO®)

February 24, 2024

Register Now!

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

March 8-9, 2024

Register Now!

Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs

View More

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

23rd Annual International Congress on the Future of Breast Cancer® West

July 12-13, 2024

Register Now!

25th Annual International Lung Cancer Congress®

July 25-27, 2024

Register Now!

2023 ASCO Direct™ Highlights: Practice-Changing Data From the Leading Oncology Conference

View More

Community Practice Connections™: 24th Annual International Lung Cancer Congress®

View More

Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

© 2023 MJH Life Sciences

All rights reserved.